NPM1 and acute myeloid leukemia: Collectively, these data showed that although FLT3-ITD mutation influences the abundance of certain immunophenotypic subsets in NPM1-mutated AML cases, the committed subgroup includes more cells with advanced myelomonocytic differentiation independently of FLT3-ITD status.